Using shRNA, silencing of S100A8/A9 expression in the TR146 human HNSCC cell line increases growth and survival and reduces Cdc2 inhibitory phosphorylation at Thr14/Tyr15. The gene discussed is IGKV1D-22; the disease is head and neck squamous cell carcinoma.